GLP ‐1 Receptor Agonist Added to Insulin versus Basal‐plus or Basal‐bolus Insulin Therapy in Type 2 Diabetes Mellitus. A Systematic Review and Meta‐analysis.

Diabetes/Metabolism Research and Reviews,Volume 0, Issue ja, -Not available-.

Source: Diabetes/Metabolism Research and Reviews - October 1, 2018 Category: Endocrinology Authors: Marco Castellana, Angelo Cignarelli, Francesco Brescia, Luigi Laviola, Francesco Giorgino Source Type: research